Analyst Price Targets — THC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 14, 2026 12:24 pm | — | Raymond James | $285.00 | $267.27 | TheFly | Tenet Healthcare price target raised to $285 from $275 at Raymond James |
| August 10, 2026 11:21 am | — | Mizuho Securities | $290.00 | $262.13 | TheFly | Tenet Healthcare price target raised to $290 from $250 at Mizuho |
| August 3, 2026 11:38 am | Stephen Baxter | Wells Fargo | $281.00 | $254.78 | TheFly | Tenet Healthcare price target raised to $281 from $231 at Wells Fargo |
| July 28, 2026 10:23 pm | Scott Fidel | Goldman Sachs | $305.00 | $262.63 | TheFly | Tenet Healthcare price target raised to $305 from $252 at Goldman Sachs |
| July 28, 2026 11:53 am | David MacDonald | Truist Financial | $290.00 | $243.36 | TheFly | Tenet Healthcare price target raised to $290 from $270 at Truist |
| July 28, 2026 10:38 am | Michael Ha | Robert W. Baird | $280.00 | $243.36 | TheFly | Tenet Healthcare price target raised to $280 from $210 at Baird |
| July 27, 2026 1:57 pm | — | Stephens | $285.00 | $245.35 | TheFly | Tenet Healthcare price target raised to $285 from $250 at Stephens |
| July 27, 2026 12:57 pm | — | UBS | $308.00 | $245.61 | TheFly | Tenet Healthcare price target raised to $308 from $288 at UBS |
| July 27, 2026 12:54 pm | — | Piper Sandler | $308.00 | $246.84 | StreetInsider | Tenet Healthcare (THC) PT Raised to $308 at UBS |
| July 27, 2026 12:19 pm | — | Morgan Stanley | $274.00 | $243.89 | TheFly | Tenet Healthcare price target raised to $274 from $254 at Morgan Stanley |
Latest News for THC
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, beginning at 12:45 p.m. Eastern Time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet…
TXO, GS, SNDK, TLS and THC have been added to the Zacks Rank #1 (Strong Buy) List on September 1, 2026.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SLDE, LEG and THC made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 25th, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for THC.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.